NBC Nightly News – Dr. Sam Gandy: "Detecting Alzheimer's"
September 7, 2012
Scientists discovered the brain changes leading to Alzheimer's begin decades before any symptoms, which may mean people at risk could be identified long before they start to have any memory loss.
EurekAlert.com - "Rejected Drug May Protect Against Toxic Substance Common to Both Alzheimer’s and Parkinson’s Diseases"
August 13, 2012
Latrepirdine, which failed in U.S. Clinical Trials of Alzheimer’s Disease, is showing new potential in an animal model.
Researchers Rediscover Potential of Rejected Alzheimer’s Drug to Arrest Progression of Disease in Mice
August 8, 2012
Study Suggests that Latrepirdine, Which Previously Failed in Clinical Trials, May Be Successful if Tested on Patients with Earlier Stages of the Disease
Mount Sinai Performs First Imaging Test to Detect Alzheimer's Disease in the Clinical Setting
June 20, 2012
The new technique is expected to play a critical role in Alzheimer's disease diagnosis and in research leading to a cure.
Grape-Derived Compound Prevents Alzheimer's Disease Progression in Mice
May 2, 2012
Mount Sinai researchers harnessed the beneficial effects of grape-seed extract on the brain and developed a biosynthetic compound that improves cognition in mice.
Gene Associated with Type 2 Diabetes Is Low in People with Alzheimer’s Disease
October 12, 2010
A study in the journal Aging Cell shows that people with Alzheimer’s disease have a low level of the gene PGC-1, which regulates glucose.
The Mount Sinai Medical Center Named One of the Best Hospitals in the United States by U.S. News and World Report
July 22, 2010
Mount Sinai tops the list for geriatrics and comes in high for numerous other specialties, including gastroenterology and cardiology.
Study Reveals That Dimebolin Therapy May Contribute to Neuron Deterioration
January 7, 2010
A study led by Mount Sinai researchers suggests that dimebolin increases levels of beta amyloid, a protein related to the plaque buildup found in the brains of people with Alzheimer's.
Mount Sinai Researchers Take Part in Phase 2 Clinical Trial Testing Gene Therapy for Alzheimer's Disease Patients
November 16, 2009
Mount Sinai School of Medicine is one of 12 sites participating in the Phase 2 study of neurological interventions for Alzheimer's disease research.
Mount Sinai Study Concludes Cognitive Testing of Elderly by Phone Is Effective Evaluation Method
September 15, 2009
Cognitive testing of the elderly by telephone is generally as effective as in-person testing, according to a study by Mount Sinai investigators.
The Mount Sinai Medical Center Named to U.S. News Honor Roll
July 16, 2009
Mount Sinai received high marks in 11 of 16 specialties to earn its Honor Roll ranking among U.S. News & World Report's "Best Hospitals" for 2009-2010.
Mount Sinai Researchers Find New Alzheimer's Disease Treatment Promising
July 12, 2009
Study hopes to show that the new treatment is safe and effective for stabilizing cognitive performance for patients with mild to moderate forms of Alzheimer's disease.